225 related articles for article (PubMed ID: 10617633)
21. The oncogenic 70Z Cbl mutation blocks the phosphotyrosine binding domain-dependent negative regulation of ZAP-70 by c-Cbl in Jurkat T cells.
van Leeuwen JE; Paik PK; Samelson LE
Mol Cell Biol; 1999 Oct; 19(10):6652-64. PubMed ID: 10490604
[TBL] [Abstract][Full Text] [Related]
22. The Cbl family of signal transduction molecules.
Smit L; Borst J
Crit Rev Oncog; 1997; 8(4):359-79. PubMed ID: 9622055
[TBL] [Abstract][Full Text] [Related]
23. Cbl-b positively regulates Btk-mediated activation of phospholipase C-gamma2 in B cells.
Yasuda T; Tezuka T; Maeda A; Inazu T; Yamanashi Y; Gu H; Kurosaki T; Yamamoto T
J Exp Med; 2002 Jul; 196(1):51-63. PubMed ID: 12093870
[TBL] [Abstract][Full Text] [Related]
24. A direct interaction between the adaptor protein Cbl-b and the kinase zap-70 induces a positive signal in T cells.
Zhang Z; Elly C; Qiu L; Altman A; Liu YC
Curr Biol; 1999 Feb; 9(4):203-6. PubMed ID: 10074432
[TBL] [Abstract][Full Text] [Related]
25. Functional and physical interactions of Syk family kinases with the Vav proto-oncogene product.
Deckert M; Tartare-Deckert S; Couture C; Mustelin T; Altman A
Immunity; 1996 Dec; 5(6):591-604. PubMed ID: 8986718
[TBL] [Abstract][Full Text] [Related]
26. RING finger mutations that abolish c-Cbl-directed polyubiquitination and downregulation of the EGF receptor are insufficient for cell transformation.
Thien CB; Walker F; Langdon WY
Mol Cell; 2001 Feb; 7(2):355-65. PubMed ID: 11239464
[TBL] [Abstract][Full Text] [Related]
27. Adaptor function for the Syk kinases-interacting protein 3BP2 in IL-2 gene activation.
Deckert M; Tartare-Deckert S; Hernandez J; Rottapel R; Altman A
Immunity; 1998 Nov; 9(5):595-605. PubMed ID: 9846481
[TBL] [Abstract][Full Text] [Related]
28. A novel phosphotyrosine-binding domain in the N-terminal transforming region of Cbl interacts directly and selectively with ZAP-70 in T cells.
Lupher ML; Reedquist KA; Miyake S; Langdon WY; Band H
J Biol Chem; 1996 Sep; 271(39):24063-8. PubMed ID: 8798643
[TBL] [Abstract][Full Text] [Related]
29. Requirements of multiple domains of SLI-1, a Caenorhabditis elegans homologue of c-Cbl, and an inhibitory tyrosine in LET-23 in regulating vulval differentiation.
Yoon CH; Chang C; Hopper NA; Lesa GM; Sternberg PW
Mol Biol Cell; 2000 Nov; 11(11):4019-31. PubMed ID: 11071924
[TBL] [Abstract][Full Text] [Related]
30. The Cbl proto-oncogene product negatively regulates the Src-family tyrosine kinase Fyn by enhancing its degradation.
Andoniou CE; Lill NL; Thien CB; Lupher ML; Ota S; Bowtell DD; Scaife RM; Langdon WY; Band H
Mol Cell Biol; 2000 Feb; 20(3):851-67. PubMed ID: 10629042
[TBL] [Abstract][Full Text] [Related]
31. Regulation of ubiquitin protein ligase activity in c-Cbl by phosphorylation-induced conformational change and constitutive activation by tyrosine to glutamate point mutations.
Kassenbrock CK; Anderson SM
J Biol Chem; 2004 Jul; 279(27):28017-27. PubMed ID: 15117950
[TBL] [Abstract][Full Text] [Related]
32. Identification of the site in the Syk protein tyrosine kinase that binds the SH2 domain of Lck.
Couture C; Deckert M; Williams S; Russo FO; Altman A; Mustelin T
J Biol Chem; 1996 Sep; 271(39):24294-9. PubMed ID: 8798676
[TBL] [Abstract][Full Text] [Related]
33. Structure of the amino-terminal domain of Cbl complexed to its binding site on ZAP-70 kinase.
Meng W; Sawasdikosol S; Burakoff SJ; Eck MJ
Nature; 1999 Mar; 398(6722):84-90. PubMed ID: 10078535
[TBL] [Abstract][Full Text] [Related]
34. The Cbl protooncogene product: from an enigmatic oncogene to center stage of signal transduction.
Miyake S; Lupher ML; Andoniou CE; Lill NL; Ota S; Douillard P; Rao N; Band H
Crit Rev Oncog; 1997; 8(2-3):189-218. PubMed ID: 9570294
[TBL] [Abstract][Full Text] [Related]
35. Molecular basis for a direct interaction between the Syk protein-tyrosine kinase and phosphoinositide 3-kinase.
Moon KD; Post CB; Durden DL; Zhou Q; De P; Harrison ML; Geahlen RL
J Biol Chem; 2005 Jan; 280(2):1543-51. PubMed ID: 15536084
[TBL] [Abstract][Full Text] [Related]
36. Cbl-mediated negative regulation of platelet-derived growth factor receptor-dependent cell proliferation. A critical role for Cbl tyrosine kinase-binding domain.
Miyake S; Mullane-Robinson KP; Lill NL; Douillard P; Band H
J Biol Chem; 1999 Jun; 274(23):16619-28. PubMed ID: 10347229
[TBL] [Abstract][Full Text] [Related]
37. Reconstitution of T cell antigen receptor-induced Erk2 kinase activation in Lck-negative JCaM1 cells by Syk.
Williams S; Couture C; Gilman J; Jascur T; Deckert M; Altman A; Mustelin T
Eur J Biochem; 1997 Apr; 245(1):84-90. PubMed ID: 9128727
[TBL] [Abstract][Full Text] [Related]
38. A conserved DpYR motif in the juxtamembrane domain of the Met receptor family forms an atypical c-Cbl/Cbl-b tyrosine kinase binding domain binding site required for suppression of oncogenic activation.
Peschard P; Ishiyama N; Lin T; Lipkowitz S; Park M
J Biol Chem; 2004 Jul; 279(28):29565-71. PubMed ID: 15123609
[TBL] [Abstract][Full Text] [Related]
39. Point mutation of a tyrosine in the linker region of Syk results in a gain of function.
Sada K; Zhang J; Siraganian RP
J Immunol; 2000 Jan; 164(1):338-44. PubMed ID: 10605028
[TBL] [Abstract][Full Text] [Related]
40. Differential intrinsic enzymatic activity of Syk and Zap-70 protein-tyrosine kinases.
Latour S; Chow LM; Veillette A
J Biol Chem; 1996 Sep; 271(37):22782-90. PubMed ID: 8798454
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
